Discover
IMMX
Immix Biopharma, Inc.
9.83
2 x 7.30
2 x 12.33
bid
ask
-
0.48
4.66%
2 @ 04:00 PM
9.90 +0.07 (0.71%)
| Ytd | 87.95% | |
| 1y | 348.86% |
9.60
day range
10.29
1.94
52 week range
11.61
| Open | 10.15 | Prev Close | 10.31 | Low | 9.60 | High | 10.29 | Mkt Cap | 699.80M |
| Vol | 1.82M | Avg Vol | 1.36M | EPS | -0.92 | P/E | N/A | Forward P/E | -3.96 |
| Beta | 0.10 | Short Ratio | 2.94 | Inst. Own | 17.64% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 9.24 | 200-d Avg | 6.61 | 1yr Est | 7.00 |
IMMX News
benzinga.com
Immix Biopharma Analyst Bullish But Flags Safety, Adoption Questions
BofA Securities initiates Immix Biopharma with Buy rating, citing NXC-201's potential in AL amyl
benzinga.com
This Intuit Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday
Wall Street analysts updated ratings for CURB, INTU, ENGN. See their outlooks and targets at Benzing
benzinga.com
This Talen Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Analysts changed outlook on top Wall Street names. See all changes on our analyst ratings page. Chec
benzinga.com
B of A Securities Initiates Coverage On Immix Biopharma with Buy Rating, Announces Price Target of $
B of A Securities analyst Tazeen Ahmad initiates coverage on Immix Biopharma (NASDAQ:IMMX) with a